Celtiss Therapeutics Private Limited

Celtiss Therapeutics Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U74999TG2018PTC123064 Incorporated 16 March 2018 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma DPIIT Startup MSME · Micro
Revenue · FY 2019
₹50.64 Lakh
Latest filing
Net loss · FY 2019
₹2.14 Cr
Net margin -423.3%
EBITDA · FY 2019
-₹2.14 Cr
EBITDA margin -421.8%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Employees · EPFO
4
Provident fund records
Directors on board
2
As per MCA filings

About Celtiss Therapeutics Private Limited

Data last updated:

Celtiss Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 March 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2018PTC123064. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Shailaja Sayam Sekhar and Sayam Chandra Sekhar.

Its last annual general meeting (AGM) was held on 29 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at # 12 – 1 – 7/4 Arunodaya Nagar Nagole, Hyderabad, Telangana, India – 500068.

As per the financials filed for FY 2019, the company reported a revenue of ₹50.64 Lakh. For the same year it recorded a net loss of ₹2.14 Cr (net margin -423.3%) and EBITDA of -₹2.14 Cr (EBITDA margin -421.8%).

The company has about 4 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Celtiss. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 2 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹49 Lakh; the latest was in September 2020.

Celtiss Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0051366). For more details, the company can be reached via its website celtisslimited.com.

Company details

CIN U74999TG2018PTC123064
Registration Number 123064
Incorporation Date 16 March 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0051366

Recognitions & Rankings of Celtiss Therapeutics

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-TS-02-0051366

Contact details

Celtiss Therapeutics Private Limited's registered office is in Hyderabad, Telangana. Its website is celtisslimited.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    # 12 – 1 – 7/4 Arunodaya Nagar Nagole, Hyderabad, Telangana, India – 500068
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Celtiss Therapeutics Private Limited, buy the company report.

Comprehensive company report
Celtiss Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Celtiss Therapeutics operates one associated brand: Celtiss. Each brand links to its own profile.

BrandDescriptionWebsite
Creates innovative technologies for drug delivery patches and films.celtisslimited.com

Business activity

The main business activity of Celtiss Therapeutics is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Celtiss Therapeutics Private Limited, buy the company report.

Financials of Celtiss Therapeutics Private Limited

FY 2019 filings available

Celtiss Therapeutics Private Limited reported revenue of ₹50.64 Lakh for FY 2019.

Revenue · FY 2019
₹50.64 Lakh
Net loss · FY 2019
₹2.14 Cr margin -423.3%
EBITDA · FY 2019
-₹2.14 Cr margin -421.8%

Financial Statement Summary

MetricsFY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹50.64 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹2.14 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.14 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2018-19FY 2017-18
Profitability
EBITDA Margin-421.8%
Net Profit Margin-423.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Celtiss Therapeutics Private Limited, buy the company report.

Board of directors of Celtiss Therapeutics Private Limited

Celtiss Therapeutics has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Shailaja Sayam SekharDirector16 Mar 20188 Years 8 MonthsCurrent
Sayam Chandra SekharDirector16 Mar 20188 Years 8 MonthsCurrent

Auditor

Celtiss Therapeutics Private Limited is audited by NANDOORI & ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
NANDOORI & ASSOCIATESFY 2019019141S

Shareholding

The shareholding of Celtiss Therapeutics Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Celtiss Therapeutics Private Limited, buy the company report.

Deals & funding

Celtiss Therapeutics Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹49 Lakh; the latest was in September 2020.

Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹49 Lakh

Deals on record (2 of 2)

WhenDealAmountParties
Sep 2020Funding round₹49 LakhInvestors: 2 individuals
Mar 2019Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Celtiss Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Celtiss Therapeutics Private Limited has a workforce of 4 employees on its EPFO records as of Aug 2020, across 1 active EPFO establishment.

Employee count
4
Active EPFO establishments
1
Employee growth
100%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2020-214
FY 2019-20
FY 2018-19

To see the full employee and EPFO history of Celtiss Therapeutics Private Limited, buy the company report.

GST

Celtiss Therapeutics has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Celtiss Therapeutics Private Limited, buy the company report.

Recent activity

Celtiss Therapeutics Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Sayam Chandra Sekhar was appointed as Director on 16 Mar 2018.

AGM
Celtiss Therapeutics Private Limited last Annual general meeting of members was held on 29 Sep 2019 as per latest MCA records.
Filing
Celtiss Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad.
Appointed
Sayam Chandra Sekhar was appointed as Director.
Appointed
Shailaja Sayam Sekhar was appointed as Director.
Incorporation
16 Mar 2018
Celtiss Therapeutics Private Limited was registered on 16 Mar 2018 with Roc Hyderabad & aged 8 years 8 months as per MCA records.

Frequently asked questions

Celtiss Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 March 2018 (8+ years old) and is registered under CIN U74999TG2018PTC123064.

Celtiss Therapeutics has 2 current directors:

The latest financial statements of Celtiss Therapeutics on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 29 September 2019. Year-wise statements from FY 2018 are in the company report.

No. Celtiss Therapeutics has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Celtiss Therapeutics is U74999TG2018PTC123064. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Celtiss Therapeutics has 4 court cases on record: 1 filed by the company and 3 filed against it. 2 are pending. Most are in the district courts.

Celtiss Therapeutics was incorporated on 16 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.

Celtiss Therapeutics has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹49 Lakh; the latest was in September 2020.

Sayam Chandra Sekhar was appointed as Director on 16 Mar 2018. Shailaja Sayam Sekhar was appointed as Director on 16 Mar 2018.

Yes, Celtiss Therapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).